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Abstract 
Protein crystallography is a useful tool to elucidate protein structures to the 
atomic level. X-ray crystallography requires high-quality diffracting crystals, 
which can be difficult to obtain, especially for proteins. Proteins are fragile, 
sensitive to external changes, highly heterogenous and large. In addition, protein-
protein interactions are weak and scattered over a large surface area. To bring the 
large, heterogenous protein molecules into an ordered arrangement is a challenge. 
Several approaches have been explored to better promote protein crystal 
formation; for instance small molecules, polymers, and metal ions. Recently, 
organo-lanthanide complexes have been reported to work well. Lanthanide 
complexes have two advantages over the other approaches: 1) if a lanthanide 
complex is successfully incorporated into a protein, the derivatized protein will 
luminesce under UV light, and 2) lanthanide complexes possess large anomalous 
factors which are useful in X-ray crystallography. Only two classes of organo-
lanthanide complexes have been reported for use in protein crystallography; one 
is based on cyclen and the other is based on dipicolinic acid. Herein, we wish to 
present our preparation of eight derivatives of dipicolinic acid using microwave-
assisted Suzuki coupling. We found that the Suzuki reaction worked best at 140 
oC for 40 minutes and the best conditions for the hydrolysis of the diesters were 
14 equivalents of LiOH in 3:1 MeOH/H2O. Six of the compounds exhibited 
limited solubility, whereas 4-(4-carboxyphenyl)pyridine-2,6-dicarboxylic acid 
and 4-(4-aminophenyl)pyridine-2,6-dicarboxylic acid showed improved 
solubility. Sterically hindered boronic acids reacted less efficiently and highly 
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electron-poor boronic acids did not react at all. The eight compounds will be used 
in the preparation of lanthanide complexes, which will be screened against nine 
proteins. 
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1. Introduction 
The common bottleneck in protein crystallography is to obtain high-quality 
diffracting crystals. More often in protein crystallization attempts, protein molecules 
precipitate as amorphous solids or stay in solution. The number of variables that influences 
protein crystal formation is large and unfortunately, there is no universal protocol for 
crystallizing proteins but it is rather a trial-and-error process. Physical, biochemical, and 
chemical factors that affect protein crystallization include protein purity and homogeneity, 
precipitant, pH, additive, and temperature, to name a few. Furthermore, proteins can be 
fragile and sensitive to their environment; consequently, the challenge lies in finding optimal 
crystallization conditions which also leave the protein intact.  
Two widely used techniques to crystallize proteins are vapor diffusion (sitting-drop 
and hanging-drop) and batch crystallization.2,3 The theory behind these methods is to slowly 
bring protein concentration to supersaturation and with luck, the protein nucleates 
spontaneously from the solution and continues to grow. Since the line between the 
supersaturated state and the precipitation zone is fine, the protein may precipitate instead of 
crystallize.  
In a typical vapor diffusion experiment, a container is partially filled with precipitant 
solution at a certain concentration and pH.3 A drop consisting of a microliter-volume of the 
protein solution at a certain concentration (usually 5-50 mg/mL) and an equal volume of the 
precipitant solution is placed, separate from the precipitant reservoir, in the container. The 
container is then sealed to allow equilibrium to be reached between the precipitant reservoir 
and the drop. Initially, the drop is undersaturated. As the system approaches equilibrium, the 
concentrations of protein and precipitant in the drop increase until supersaturation is reached 
 1
which in theory allows spontaneous nucleation. The role of the precipitant is to promote 
crystallization; however, in many cases, it fails to do so. In fact, in a 2002 report, the 
percentage of successful crystallization was estimated to 26%.4 Therefore, alternative 
approaches in promoting crystallization are necessary. One solution is the addition of an 
additive which will act as the principle precipitant. Small molecules5,6 , polymers7,8 as well as 
mono- and divalent metal ions9,10 have been demonstrated to work well. Herein is a selection 
of recent studies of the above mentioned additives described. 
McPherson et al. carried out laborious work in search for classes of small molecules 
that promote crystallization. All together, 500 small molecules and 81 proteins were screened 
in roughly 50000 crystallization trials.5,11 The small molecules were added as mixtures based 
on their similarity in structure and chemistry. They included bioactive and chemical 
compounds, which could affect the physical properties of the proteins, such as solubility, 
surface and inter-macromolecular interactions. An interesting feature of the studies is that 
only two crystallization conditions were used, one was based on 30% PEG 3350 and the 
other on 50% TacsimateTM (mixture of seven organic acids) at pH 7. Small molecules with 
charged functional groups such as dicarboxylic acids and diamines or both were found to 
better promote crystallization. Crystal structures of selected derivatized proteins displayed 
electrostatic interactions between the proteins and the additives. Further, the latter served as 
bridges to connect protein molecules together. In some cases, however, the small molecules 
were not found in the crystallized proteins but rather the precipitant (example thaumatin with 
protamine as additive), or they somehow induced conformational changes in the proteins, 
which were more favorable towards crystal formation (hen egg-white lysozyme with 
different additives).11 In other cases, they bound tightly to the active sites of the proteins 
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(bovine ribonuclease A with dGMP as additive).11 Some proteins were found to co-
crystallize with one of the components in the small molecules mixture suggesting that they 
could select from a mixture of structurally and chemically similar compounds the most 
suitable for self-assembly (bovine trypsin with mellitic acid).11 
McPherson et al. also investigated the capability of polymers in promoting protein 
crystallization. Based on the successful reports of PEG 400 as precipitant, they turned to 
water-soluble polymers of different (rather high) molecular weights, such as polyacrylic acid 
5100 and 2100, polyvinyl alcohol 15000 and polyethylene glycol 2000, at varied 
concentrations and pHs.7 Of the 24 proteins tested, 14 yielded crystals. Although most of the 
crystallized proteins were not of high quality, the studies demonstrated that polymers could 
be used as additives to promote crystallization. Brzozowski et al. screened polyglutamate-
gluosamine of low and high molecular weight against 13 proteins, ten of which had not 
previously been crystallized.8 Amide coupling of low and high molecular weight 
polyglutamic acid (LM-PGA and HM-PGA, respectively) with glucosamine using 
EDC/DMAP afforded glucosamine-LM-PGA and glucosamine-HM-PGA, respectively. The 
results showed that in 2:1 mol ratio of glucosamine:PGA, the solubility of the polymer was 
improved. Low and high molecular weight glucosamine-PGAs promoted crystallization to 
similar extent. Further, the results also showed that the PGA derivatives worked well as 
stand-alone additives, in combination with PEG or in conjunction with other additives. At the 
moment of writing, the crystal structures had not been published. 
Use of sole metal ions to encourage protein crystallization is a difficult approach 
since protein surfaces are highly heterogenous and protein-protein interactions are scattered 
over a large area; to precisely incorporate metal ions for proper coordination by proteins is a 
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challenge. Therefore, surface-mutated proteins are often used in metal-mediated protein 
crystallization. Crystallization of cytochrome cb562 studied by Tezcan et al. utilized a mutated 
form of the protein, called His4-cb562, which was modified at four positions 59, 63, 73 and 77 
with histidines.9,10 2+ Using Zn , Ni2+ 2+ and Cu , they demonstrated how the assembly of His4-
cb562 monomers could be controlled by different metal ions. At intermediate concentrations 
of Zn2+ 4 4-cb -cb and His 562, dimeric structure (Zn (His2 562)2) was observed whereas at high 
concentrations, the momomers rearranged into tetrameric structure (Zn4(His4-cb562)4) and 
thereby fully occupy the metal ion. The results showed that the self-assembly of the proteins 
is controlled by thermodynamics rather than kinetics. With Ni2+ 2+ and Cu , the monomers 
formed a different dimeric structure with Cu2+ (Cu2(His4-cb562)2) and trimeric structure with 
Ni2+ (Ni2(His4-cb562) ). 3
Recently, organo-lanthanide complexes have emerged successfully in promoting 
protein crystallization.11,12,13,14,15 In a way, lanthanide complexes interact with proteins in a 
similar manner as small molecules (via intermolecular electrostatic interactions albeit 
through the organo moiety). However, lanthanide complexes have two advantages over small 
molecules, polymers and divalent metals. One is that the derivatized protein crystals can be 
visualized with UV light thanks to the physico-chemical properties of the lanthanides. In 
addition, lanthanides also assist in solving X-ray structures due to their large anomalous 
factors. 
The organo component in an organo-lanthanide complex sensitizes the lanthanide ion 
as such the latter displays enhanced luminescence under UV light. The organo compound 
also provide anchor sites to which other molecules can bind. In a 2008 report, Pompidor et 
al. provided a description of the interaction of tris(dipicolinate)-lanthanide salt 1 (Figure 1), 
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hereafter called [Ln(dpa)3]3-, and hen egg-white lysozyme (HEWL).12 The complex bound to 
HEWL intermolecularly via hydrogen bonding between carboxyl groups of the complex and 
arginine residues of the protein. Co-crystal of the protein-complex luminesced under UV 
light (λ 3+ 3+ = 254 nm) due to the indirect excitation of Eu  or Tb  by dpa.  ex
                  
Figure 1. Representative structure of tris(dipicolinate)-lanthanide complexes which have been used in protein 
crystallography. Left: General structure of [Ln(dpa)3]3-. Right: 3-D representation of [Eu(dpa)3]3-. Three 
dipicolinates coordinate to Eu3+ in a propeller-like fashion. Red = oxygen, blue = nitrogen, grey = carbon, cyan 
= Eu3+. Hydrogens have been omitted for clarity. Reproduced from ref 12 using CHIMERA. 
 
To further understand how [Ln(dpa) ]3-3  (1) bound to HEWL and how strong the 
complexation was, EtGua+ ion mimicking guanidinium side chain of arginine was co-
crystallized with the complex. The co-crystal structure of (EtGua)3[Tb(dpa) ]·2H3 2O revealed 
the participation of the primary amine and imine of guanidinium acting as hydrogen-bond 
donors and of two carboxylates from the same or different dipicolinate acting as hydrogen-
bond acceptors. The strong affinity of EtGua+ for [Tb(dpa) ]3-3  also existed in solution. To 
determine the association constants of complexation, eight 1H-NMR titration experiments 
were conducted, each experiment varied in either the initial concentration of Tb3+ or in the 
counterion of [Tb(dpa) ]3-3 . As the concentration of EtGuaCl increased, the ethyl protons 
steadily shifted upfield until the solution was saturated with EtGuaCl (approximately 24 
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equivalents). By fitting the experimental data to the corresponding calculated shifts using 
least-square method, four association constants could be determined. The average overall 
association constant for the complexation is K = K K K1 2 3 ≈ 61 (±11) × 17 (±4) × 4 (±0.5) ≈ 
103.7 (±0.2), where K1, K2 and K3 are association constants of (EtGua)[Tb(dpa) ]2-3 , 
(EtGua)2[Tb(dpa) ]-, (EtGua)3 3[Tb(dpa) ], respectively. 3
Following their successful results, Pompidor et al. attempted to co-crystallize 1 with 
other proteins, namely thaumatin, turkey egg-white lysozyme, urate oxidase, xylanase and 
porcine pancreatic elastase.13 In all cases, the proteins bound to the complex through 
hydrogen-bonding between hydrogen-bond donors of the protein and the carboxylate 
oxygens of the dipicolinate. Moreover, co-crystal structures of derivatized HEWL and 
xylanase, respectively, revealed a new crystal form for the proteins whereas the rest of the 
derivatized proteins crystallized in their native form. 
Talon et al. expanded the idea of using [Ln(dpa) ]3-3  to crystallize proteins to be 
generally applicable to derivatives of dipicolinic acid.14 Three (4-substituted)-4-
triazolopicolinic acids were prepared via copper-catalyzed azide-alkyne cycloaddition 
(Figure 2). HEWL readily co-crystallized with charged (2, 3) and neutral (4) lanthanide 
complexes in its native crystal form. The co-crystal structure revealed, in addition to the 
electrostatic interactions, additional π-π interactions between the triazole ring of the complex 
and phenyl ring of tryptophan. Consequently, derivatized HEWL could be obtained at lower 
concentrations of lanthanide complexes. Crystallization of derivatized thaumatin was 
successful with charged (2, 3) lanthanide complexes (also at lower concentrations of the 
complexes, although it is unclear why it was the case) but it failed to co-crystallize with the 
neutral (4) lanthanide complex. This is thought to be because, unlike HEWL, thaumatin does 
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not have accessible hydrophobic residues to establish interactions with the uncharged 
complex. 
 
Figure 2. Structural variation of [tris(dipicolinate)-Eu]3-. 
 
Other chelating agents for Ln3+ that have been successfully employed in protein 
crystallography are based on cyclen (tetraazacyclododecane) (Figure 3, left).15 Unlike 
dipicolinic acid, wherein three tridentate dipicolinates coordinate to one Ln3+, cyclen acetic 
acid derivatives are septadentate (6) or octadentate (5, 7, 8) forming a cage around one Ln3+. 
This leaves lanthanide ion with unoccupied sites, which can be filled by water molecules 
(Figure 3, right). 
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Figure 3. Examples of cyclen derivatives used as chelating agents for Ln3+. Left: Except for DO3A, which is a 
septadentate ligand, HPDO3A, DOTA and DOTMA are octadentate. Right: 3-D representation of Gd-HPDO3A 
complex. Water forms a ninth ligand to the lanthanide ion. Red = oxygen, blue = nitrogen, grey = carbon, 
magenta = Gd3+. Hydrogens have been omitted for clarity. Reproduced from ref 6 using CHIMERA. 
 
Gd-5 complex is neutral and co-crystallizes with HEWL at high concentrations 
without damaging the derivatized crystal. Two Gd-5 complexes occupy two sites of one 
HEWL molecule. At each binding site, the hydrophobic cyclen interacts with tryptophan of 
the protein while the hydrophilic carboxylates and hydroxyl group form a hydrogen-bonding 
network with hydrophilic residues of the protein.15a At low concentrations of the Gd-5 
complex, only one site is occupied. Gd-5 complex also readily co-crystallizes with catalase 
and urate oxidase. Replacing Gd3+ for Lu3+ 3+ or Yb  did not affect the binding mode of the 
complex with the protein.15c Similarly, derivatized HEWL, urate oxidase and chimeric 
ornithine carbamoyl transferase could be obtained with complexes of Gd3+ and other cyclen 
derivatives.15b,15d 
Sensitized lanthanide complexes used in protein crystallography is still an unexplored 
field, which we would like to investigate. Employing dipicolinic acid derivatives is a 
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promising path towards achieving protein crystal structures. Dipicolinic acid and its 
derivatives have several advantages over cyclen derivatives. They strongly and fully 
coordinate to the lanthanide ion allowing the possibility to crystallize proteins at low 
concentrations and disallowing water to coordinate to the ion. They are noninvasive to 
HEWL (as opposed to HPDO3A) and are able to form new crystal forms with proteins. Our 
interest and quest were therefore to explore other derivatives of dipicolinic acid to be 
crystallized with lanthanides. We were particularly interested in pursuing symmetrical 
adducts of dipicolinic acid as symmetry will reduce the number of different atoms diffracted 
in X-ray crystallographic experiments. Consequently, a series of 4-aryl dipicolinic acids were 
constructed from 4-bromo dipicolinic acid and different aryl boronic acids via Suzuki cross-
coupling. Among metal-catalyzed cross-coupling reactions for C-C bond formation, Suzuki-
Miyaura coupling is probably one of the most widely used. It relies on palladium(0) to 
mediate the construction of biaryls from aryl halides and organoboron compounds.16 The 
proposed mechanism for the Suzuki coupling is given in Scheme 1. 
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Scheme 1. Proposed mechanism of Pd(0)-catalyzed Suzuki coupling reactions. 
 
There are a tremendous number of papers reporting the Suzuki coupling under 
different reaction conditions, all of which are to improve the reaction and/or to address 
incompatibility of unreactive boronic acids and/or aryl halides. Conventional Suzuki 
coupling is carried out under inert atmosphere. However, the reaction has demonstrated to 
work well in microwave without providing inertness.17 Microwave-assisted Suzuki coupling 
is convenient; therefore, we chose this protocol in our preparation of dipicolinic acid 
derivatives.  
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2. Results and Discussion 
Our scaffold dimethyl 4-bromopyridine-2,4-dicarboxylate (10) was obtained in one 
step by brominating chelidamic acid 9 with PBr5 followed by esterification with methanol 
(Scheme 2).18
N
OH
OH
O
HO
O
1) PBr5 (4.8 eq)
>3 h, 90oC
2) MeOH
CHCl3
N
Br
OMe
O
MeO
O
109   
Scheme 2. Synthesis of the starting material 4-bromopyridine-2,6-dicarboxylate (10). 
 
Aryl-aryl coupling of 10 with boronic acids via microwave-assisted Suzuki coupling 
afforded the corresponding 4-arylpyridine-2,6-dicarboxylates. Hydrolysis of the diesters 
yielded diacids in low to moderate overall yields (Table 1, entry 1−8). 
In an attempt to optimize the Suzuki coupling, several parameters were investigated. 
Our initial approach at 120oC showed conversion of 10 to coupling products as indicated by 
HPLC and LC/MS. With 10 degree increment, the reaction showed higher conversion and 
was further improved at 140oC. Longer reaction times also seemed to enhance the product 
formation (Table 1, entry 4 and 6). However, as we increased the reaction times beyond 60 
minutes, the catalyst began to decompose. Additional optimization by increasing the amount 
of boronic acid from 1 equivalent to 1.5 equivalents did not affect the coupling. 
Unfortunately, we could not optimize the base, the solvent or the catalyst due to time 
constraints. 
In addition to the above mentioned boronic acids (Table 1, entry 1−8), we also tried 
to couple several fluorine-containing phenylboronic acids with 10 (Table 1, entry 9−11). 
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Difluorophenyl adducts were detected by HPLC and LC/MS whereas tetrafluorophenyl 
boronic acid failed to undergo Suzuki coupling even at elevated temperatures and prolonged 
reaction times. The results could be explained by electronic effect wherein highly electron-
deficient substrates are inactive towards Pd-mediated coupling. As reasoned by Sakai et al. in 
the case of pentafluorophenyl boronic acid,19 we believed that the reason for the inactivity of 
tetrafluorophenyl boronic acid could be in the transmetalation or in the reductive elimination 
step. The exact cause is beyond the scope of this thesis and was therefore not investigated. 
Steric effects in Suzuki coupling were also observed. Higher yield was obtained for the less 
sterically hindered boronic acid (Table 1, entry 3 and 4).  
The conditions of the hydrolysis of the diesters were optimized to be 14 equivalents 
of LiOH in 3:1 MeOH/H2O. At lower equivalents, partial hydrolysis to monoacids was 
observed on HPLC. Same results were obtained with 6.5 equivalents of K CO2 3 in 2:1 
MeOH/H O.2
 12
  
Overall 
yield Temperature Time Entry R-B(OH) Product o2 ( C) (min) (%) 
1  140 20 43 
 
2 
 
140 30 35 
 
3  140 40 71 
 
140 7 19 
4 
 140 40 61 
 
5 
 
120 10 N
OH
O
OHO
15
CF3
F3C
1 
 
120 10 1 
6 
 
140 40 27 
 
Table 1. Reaction conditions and overall yields. The reaction progress was followed on HPLC. 
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Table 1 continued. 
 
7 
 
140 40 28 
 
8 
 
140 40 pending
 
9 
 
120 14 not isolated 
 
10 
 
140 40 not isolated 
 
- 11 140 >60 - 
 
 
In conclusion, eight 4-arylpyridine-2,6-dicarboxylic acids were synthesized via 
microwave-assisted Suzuki coupling. To the best of our knowledge, only two compounds 
have been previously made (11 and 17). Compounds 11−16 displayed very limited solubility 
in water. To address this issue of insolubility, compounds 17 and 18 containing a carboxyl 
and an amino group, respectively, were synthesized. Both compounds exhibited improved 
solubility which is important in the preparation of lanthanide complexes and in the protein 
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crystallization. If the complexes are successfully prepared, they will be used in protein 
crystallization. At the time of writing, the results were still pending. 
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3. Future directions 
4-arylpyridine-2,6-dicarboxylic acids can be further explored. However, 
hydrophilicity should be taken into consideration as such polar groups should be incorporated 
(Figure 4).  
 
Figure 4. Possible substituted 4-arylpicolinic acids to be explored. R = polar groups, such as CO2H, NH2, OH, 
CONH2, guanidinium, SO3H. 
 
In addition, we can employ the chemistry of heterocycles in click chemistry by 
coupling 4-azidopyridine-2,6-dicarboxylic acid with different terminal and internal alkynes 
(Scheme 3).  
 
Scheme 3. Use of click chemistry to form triazoles. 
 
We can also prepare secondary amines which will provide more flexibility to bind proteins 
(Scheme 4). 
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Scheme 4. Secondary amines via Schiff base. 
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4. Experimental procedure 
4.1 General 
All chemicals were used without further purification. Analytical HPLC was carried 
out on Thermo Betabasic-8 (5 μm, 4.6×100 mm) column with flow rate 0.8 mL/min. 
Preparative HPLC was performed on XBridgeTM C18 (5 μm, 19×150 mm) column with flow 
rate 10 mL/min. Same solvent system was used for analytical and preparative HPLC, which 
is 0.1% TFA in H2O and 0.1% TFA in MeCN. Low-resolution mass spectra were obtained on 
Thermo Finnigan Surveyor System equipped with PDA Plus Detector and Single Quadrupole 
LC/MS using Betabasic-18 (5 μm, 2.1×50 mm) column. NMR spectra were obtained on 
JEOL ECX-400P and processed using software Delta 4.3.6. 
 
Dimethyl 4-bromopyridine-2,6-dicarboxylate (10).18 Chelidamic acid (6.08 g, 30 
mmol) and PBr  (62 g, 144 mmol, 4.8 eq) were heated at 90oC for 3 h during which PBr5 5 
melted and chelidamic acid formed a glue-like melt. Chloroform (50 mL) was added to the 
reaction mixture upon which a solid precipated. The mixture was filtered, and the filtrate was 
cooled to 0oC. At this temperature, MeOH was added dropwise. The white solid was 
collected and recrystallized from MeOH to give the titled compound as white crystals (5.2 g, 
19 mmol, 63%). 1 13H-NMR (400 MHz, CDCl ): δ (ppm) 8.44 (s, 2H), 4.01 (s, 6H); 3 C-NMR 
(100 MHz, CDCl ): δ (ppm) 164.1, 149.1, 135.3, 131.4, 53.6; LRMS (ESI) calcd for 3
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C H BrNO9 8 4: m/z 274.0 (M + H), found: 273.7 (100), 275.7 (99), retention time = 10.06-
10.60 min. 
General procedure for the syntheses of 4-arylpyridine-2,6-dicarboxylic acids 
(11–18).17 Dimethyl 4-bromopyridine-2,6-dicarboxylate 10, boronic acid (1 eq or 1.5 eq), 
Pd(dppf)Cl ·CH Cl2 2 2 (10 mol%) and dichloroethane were added to a microvial. Aqueous 
Cs CO2 3 (1 eq) was added to the mixture. The reaction was run in microwave reactor. After 
cooling to room temperature, the reaction mixture was extracted with EtOAc. The combined 
organic layer was washed with water, dried over MgSO4, filtered and concentrated in vacuo. 
The crude material was flashed through silica gel in hexane/EtOAc.20 The product was 
dissolved in 0.7 M LiOH·H O in MeOH/H2 2O 3:1 (14 eq). The reaction was run at room 
temperature for 1 h. The reaction mixture was cooled to 0oC, then acidified with aqueous 
HCl during which a precipitate was formed. Water was removed and the residue was purified 
by reverse HPLC. 
 
4-Phenylpyridine-2,6-dicarboxylic acid (11). Dimethyl 4-bromopyridine-2,6-
dicarboxylate 10 (260 mg, 0.95 mmol), phenylboronic acid (116 mg, 0.95 mmol), 
Pd(dppf)Cl ·CH Cl2 2 2 (78 mg, 0.095 mmol, 10 mol%), dichloroethane (2 mL), aqueous 
Cs2CO  (2 mL, 0.475 M, 1 eq). The reaction was run in microwave at 140o3 C for 20 minutes. 
Hydrolysis with LiOH in 3:1 MeOH/H O (0.7 M, 19 mL, 13.3 mmol, 14 eq) afforded brown 2
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solid (99.7 mg, 0.41 mmol, 43% overall yield). 1H-NMR (400 MHz, methanol-d4): δ (ppm) 
8.44 (s, 2H), 7.84 (d, J = 6.9 Hz, 2H), 7.56 (m, 3H). 13C-NMR (100 MHz, methanol-d4): δ 
(ppm) 164.1, 149.1, 135.3, 131.4, 53.6; LRMS (ESI) calcd for C13H NO9 4: m/z 244.0 (M + 
H), found: 243.9, retention time = 10.31 min. 
 
4-(Biphenyl-4-yl)pyridine-2,6-dicarboxylic acid (12). Dimethyl 4-bromopyridine-
2,6-dicarboxylate 10 (203 mg, 0.74 mmol), biphenyl-4-ylboronic acid (147 mg, 0.74 mmol), 
Pd(dppf)Cl ·CH Cl2 2 2 (60 mg, 0.074 mmol, 10 mol%), dichloroethane (2 mL), aqueous 
Cs2CO  (2 mL, 0.37 M, 1 eq). The reaction was run in microwave at 140o3 C for 30 minutes. 
Hydrolysis with LiOH in 3:1 MeOH/H2O (15 mL, 0.7 M, 10.4 mmol, 14 eq) afforded brown 
solid (83 mg, 0.26 mmol, 35% overall yield). 1H-NMR (400 MHz, DMSO-d6): δ (ppm) 8.47 
(s, 2H), 8.00 (d, J = 8.3 Hz, 2H), 7.84 (d, J = 8.7 Hz, 2H), 7.73 (d, J = 7.4 Hz, 2H), 7.48 
(apparent t, J = 7.4, 7.8 Hz, 2H), 7.38 (t, J = 7.3 Hz, 1H) ; LRMS (ESI) calcd for C H19 13NO4: 
m/z 320.1 (M + H), found: 320.1, retention time = 11.44 min. 
N
OH
O
OHO
13  
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4-p-Tolylpyridine-2,6-dicarboxylic acid (13). Dimethyl 4-bromopyridine-2,6-
dicarboxylate 10 (260 mg, 0.95 mmol), p-tolylboronic acid (195 mg, 1.425 mmol, 1.5 eq), 
Pd(dppf)Cl ·CH Cl2 2 2 (78 mg, 0.095 mmol, 10 mol%), dichloroethane (2.5 mL), aqueous 
Cs2CO  (2 mL, 0.475 M, 1 eq). The reaction was run in microwave at 140o3 C for 40 minutes. 
Hydrolysis with LiOH in 3:1 MeOH/H2O (19 mL, 0.7 M, 13.3 mmol, 14 eq) afforded brown 
solid (173 mg, 0.67 mmol, 71% overall yield). 1H-NMR (400 MHz, DMSO-d6): δ (ppm) 8.39 
(s, 2H), 7.78 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 7.8, 2H), 2.34 (s, 3H). 13C-NMR (100 MHz, 
DMSO-d6): δ (ppm) 166.2, 150.3, 150.2, 140.7, 133.5, 130.6, 127.5, 124.4, 21.4; LRMS 
(ESI) calcd for C14H11NO : m/z 258.1 (M + H), found: 258.0, retention time = 10.52 min. 4
 
4-Mesitylpyridine-2,6-dicarboxylic acid (14). Dimethyl 4-bromopyridine-2,6-
dicarboxylate 10 (260 mg, 0.95 mmol), mesitylboronic acid (234 mg, 1.425 mmol, 1.5 eq), 
Pd(dppf)Cl ·CH Cl2 2 2 (78 mg, 0.095 mmol, 10 mol%), dichloroethane (2.5 mL), aqueous 
Cs2CO  (2 mL, 0.475 M, 1 eq). The reaction was run in microwave at 140o3 C for 40 minutes. 
Hydrolysis with LiOH in 3:1 MeOH/H2O (19 mL, 0.7 M, 13.3 mmol, 14 eq) afforded white 
solid (167 mg, 0.58 mmol, 61% overall yield). 1H-NMR (400 MHz, DMSO-d6): δ (ppm) 7.91 
(s, 2H), 6.95 (s, 2H), 2.24 (s, 3H), 1.89 (s, 6H). 13C-NMR (100 MHz, DMSO-d6): δ (ppm) 
166.1, 151.9, 149.4, 138.1, 135.1, 135.0, 128.9, 128.6, 21.2, 20.7; LRMS (ESI) calcd for 
C16H15NO : m/z 286.1 (M + H), found: 286.3, retention time = 10.90 min. 4
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 4-(3,5-bis(trifluoromethyl)phenyl)pyridine-2,6-dicarboxylic acid (15). Dimethyl 
4-bromopyridine-2,6-dicarboxylate 10 (200 mg, 0.74 mmol), 3,5-bis(trifluoromethyl)phenyl 
boronic acid (191 mg, 0.74 mmol, 1 eq), Pd(dppf)Cl ·CH Cl2 2 2 (60 mg, 0.074 mmol, 10 
mol%), dichloroethane (2 mL), aqueous Cs CO2 3 (2 mL, 0.37 M, 1 eq). The reaction was run 
in microwave at 120oC for 10 minutes. Hydrolysis with LiOH in 3:1 MeOH/H2O (15 mL, 0.7 
M, 10.4 mmol, 14 eq) afforded white solid (3 mg, 7.9 μmol, 1% overall yield). 1H-NMR (400 
MHz, methanol-d4): δ (ppm) 8.65 (s, 2H), 8.43 (s, 2H), 8.15 (s, 1H); LRMS (ESI) calcd for 
C15H F NO : m/z 380.0 (M + H), found: 397.7 (100), 380.3 (93), retention time = 11.36 min. 7 6 4
 
4-(4-Fluorophenyl)pyridine-2,6-dicarboxylic acid (16). Dimethyl 4-bromopyridine-
2,6-dicarboxylate 10 (260 mg, 0.95 mmol), 4-fluorophenylboronic acid (200 mg, 1.425 
mmol, 1.5 eq), Pd(dppf)Cl ·CH Cl2 2 2 (78 mg, 0.095 mmol, 10 mol%), dichloroethane (2.5 
mL), aqueous Cs2CO  (2 mL, 0.475 M, 1 eq). The reaction was run in microwave at 140o3 C 
for 40 minutes. Hydrolysis with LiOH in 3:1 MeOH/H O (19 mL, 0.7 M, 13.3 mmol, 14 eq) 2
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afforded off-white solid (151 mg, 0.52 mmol, 27% overall yield). 1H-NMR (400 MHz, 
methanol-d4): δ (ppm) 8.57 (s, 2H), 7.90 (dd, J = 8.7 Hz, 2H), 7.30 (t, J = 8.7 Hz, 2H); 
LRMS (ESI) calcd for C18H FNO8 4: m/z 262.1 (M + H), found: 261.8, retention time = 10.22 
min. 
 
4-(4-Carboxyphenyl)pyridine-2,6-dicarboxylic acid (17). Dimethyl 4-
bromopyridine-2,6-dicarboxylate 10 (260 mg, 0.95 mmol), 4-boronobenzoic acid (315 mg, 
1.9 mmol, 2 eq), Pd(dppf)Cl ·CH Cl2 2 2 (78 mg, 0.095 mmol, 10 mol%), dichloroethane (2.5 
mL), aqueous Cs2CO  (2 mL, 0.475 M, 1 eq). The reaction was run in microwave at 140o3 C 
for 40 minutes. Hydrolysis with LiOH in 3:1 MeOH/H2O (19 mL, 0.7 M, 13.3 mmol, 14 eq) 
afforded white solid (76 mg, 0.26 mmol, 28% overall yield). 1H-NMR (400 MHz, methanol-
d4): δ (ppm) 8.48 (s, 2H), 8.04 (apparent q, J = 8.7 Hz, 4H); LRMS (ESI) calcd for 
C14H NO : m/z 288.1 (M + H), found: 288.0, retention time = 9.55 min. 9 6
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4-(4-Aminophenyl)pyridine-2,6-dicarboxylic acid (18). Dimethyl 4-bromopyridine-
2,6-dicarboxylate 10 (260 mg, 0.95 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)aniline (312 mg, 1.425 mmol, 1.5 eq), Pd(dppf)Cl2·CH Cl2 2 (78 mg, 0.095 mmol, 10 
mol%), dichloroethane (2.5 mL), aqueous Cs CO2 3 (2 mL, 0.475 M, 1 eq). The reaction was 
run in microwave at 140oC for 40 minutes. Hydrolysis with LiOH in 3:1 MeOH/H2O (19 mL, 
0.7 M, 13.3 mmol, 14 eq) afforded yellow solid (pending). 1H-NMR (400 MHz, methanol-
d4): δ (ppm) 8.31 (s, 2H), 7.61 (d, J = 8.7 Hz, 2H), 6.79 (d, J = 8.7 Hz, 2H); LRMS (ESI) 
calcd for C13H10N O : m/z 259.1 (M + H), found: 258.9, retention time = 9.09 min. 2 4
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